Pierrepont Therapeutics
Brooklyn, US · Founded 2020 · Delaware corporation
Founders & leadership
MW
Matthew WyckoffNamed on SEC filing
PH
Peter H. BarberNamed on SEC filing
DD
Daniel DiPietroNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$2.1M disclosed across 1 round · 2024
▶$2.1MraisedApr 2024 · 2 investors · PharmaceuticalsRule 506(b)
▶$2.1MraisedApr 2024 · 2 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Matthew WyckoffDirector
- Peter H. BarberExecutive Officer, Director
- Daniel DiPietroDirector
- Offering amount
- $5.9M
- Amount sold
- $2.1M
- First sale
- Apr 2024
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Pierrepont Therapeutics raised?
- Pierrepont Therapeutics has disclosed $2.1M raised across 1 round.
- Where is Pierrepont Therapeutics headquartered?
- Pierrepont Therapeutics is headquartered in Brooklyn, US.